Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Wildemann

Showing results (51-60 of 204) with videos related to

Pageof 21
Sort By:
Plos One|May 13, 2016
Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple SclerosisMona Laible, Sven Jarius, Friedericke Mackensen, et al.
Neurology|June 11, 2017
Failure of alemtuzumab therapy to control MOG encephalomyelitisBrigitte Wildemann, Sven Jarius, Alexander Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive caseSven Jarius, Imke Metz, Fatima Barbara König, et al.
Journal of the Neurological Sciences|October 10, 2017
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patientsMelissa Bouzar, Smail Daoudi, Samira Hattab, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?Jürgen Haas, Katharina Schneider, Alexander Schwarz, et al.
Clinical Immunology (Orlando, Fla.)|October 16, 2009
Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activityChristian Jacobi, Maren Claus, Brigitte Wildemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell deathBenedikt Fritzsching, Nina Oberle, Nadine Eberhardt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 25, 2018
Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRIKianush Karimian-Jazi, Brigitte Wildemann, Ricarda Diem, et al.
Journal of the Neurological Sciences|March 15, 2011
An unusual case of optic neuritisDaniela Doegel, Wolf Mueller, Martina Deckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2013
Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosisAlexander Schwarz, Marijana Schumacher, Daniel Pfaff, et al.
Pageof 21

Showing results (51-60 of 204) with videos related to

Sort By:
Pageof 21
Plos One|May 13, 2016
Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple SclerosisMona Laible, Sven Jarius, Friedericke Mackensen, et al.
Neurology|June 11, 2017
Failure of alemtuzumab therapy to control MOG encephalomyelitisBrigitte Wildemann, Sven Jarius, Alexander Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive caseSven Jarius, Imke Metz, Fatima Barbara König, et al.
Journal of the Neurological Sciences|October 10, 2017
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patientsMelissa Bouzar, Smail Daoudi, Samira Hattab, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?Jürgen Haas, Katharina Schneider, Alexander Schwarz, et al.
Clinical Immunology (Orlando, Fla.)|October 16, 2009
Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activityChristian Jacobi, Maren Claus, Brigitte Wildemann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell deathBenedikt Fritzsching, Nina Oberle, Nadine Eberhardt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 25, 2018
Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRIKianush Karimian-Jazi, Brigitte Wildemann, Ricarda Diem, et al.
Journal of the Neurological Sciences|March 15, 2011
An unusual case of optic neuritisDaniela Doegel, Wolf Mueller, Martina Deckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2013
Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosisAlexander Schwarz, Marijana Schumacher, Daniel Pfaff, et al.
Pageof 21